enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Pomalidomide - Wikipedia

    en.wikipedia.org/wiki/Pomalidomide

    Pomalidomide, sold under the brand names Pomalyst and Imnovid, [7] [8] is an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma. [7] Pomalidomide was approved for medical use in the United States in February 2013, [10] and in the European Union in August 2013. [8] It is available as a generic ...

  3. Oral Anti-Cancer Therapy Pomalidomide Now Approved by ... - AOL

    www.aol.com/news/2013-08-09-oral-anti-cancer...

    Oral Anti-Cancer Therapy Pomalidomide Now Approved by European Commission as Treatment for Patients with Relapsed/Refractory Multiple Myeloma - a Rare Form of Blood Cancer BOUDRY, Switzerland ...

  4. Oral Anti-Cancer Therapy Pomalidomide Celgene Receives ... - AOL

    www.aol.com/news/2013-05-31-oral-anti-cancer...

    Oral Anti-Cancer Therapy Pomalidomide Celgene Receives Positive CHMP Opinion as Treatment for Patients with Relapsed and Refractory Multiple Myeloma BOUDRY, Switzerland--(BUSINESS WIRE)-- Celgene ...

  5. Lenalidomide - Wikipedia

    en.wikipedia.org/wiki/Lenalidomide

    Myelosuppression is the major dose-limiting toxicity, which is not the case with thalidomide. [26] Lenalidomide may be associated with adverse effects as second primary malignancy, severe cutaneous reactions, hypersensitivity reactions, tumor lysis syndrome, tumor flare reaction, hypothyroidism, and hyperthyroidism. [6]

  6. Cereblon E3 ligase modulator - Wikipedia

    en.wikipedia.org/wiki/Cereblon_E3_ligase_modulator

    The thalidomide molecule is a synthetic derivative of glutamic acid and consists of a glutarimide ring and a phthaloyl ring (Figure 5). [15] [16] Its IUPAC name is 2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione and it has one chiral center [15] After thalidomide's selective inhibition of TNF-α had been reported, a renewed effort was put in thalidomide's clinical development.

  7. Are Weight Loss Injections Safe? What to Know Before ... - AOL

    www.aol.com/weight-loss-injections-safe-know...

    On the other hand, carrying extra weight also has a number of health risks, including heart disease, stroke, type 2 diabetes, high blood pressure, and certain types of cancer.

  8. Elotuzumab - Wikipedia

    en.wikipedia.org/wiki/Elotuzumab

    Elotuzumab is recommended through intravenous administration at 10 mg/kg each week for the first 2 cycles (each cycle is 28 days). [3] At the start of cycle 3, administer 20 mg/kg every 4 weeks, while administering the recommended dose of pomalidomide and low dose dexamethasone. [3]

  9. Dose (biochemistry) - Wikipedia

    en.wikipedia.org/wiki/Dose_(biochemistry)

    In single-dose scenarios, the patient's body weight and the drug's recommended dose per kilogram are used to determine a safe one-time dose. If multiple doses of treatment are needed in a day, the physician must take into account information regarding the total amount of the drug which is safe to use in one day, and how that should be broken up ...

  1. Related searches is pomalidomide safe dosage for women over 60 days of cancer symptoms chart

    pomalidomide and myelomapomalidomide inhibitor